Coussons, P.J., Baig, S., Fanutti, C. and Grant, R. (2005) Novel tissue remodelling roles for human recombinant erythropoietin. Biochemical Society Transactions, 33(5), pp. 1129-1130. ISSN (print) 0300-5127
Full text not available from this archive.Abstract
rHuEPO (recombinant human erythropoietin) is a haemopoietic growth factor and a primary regulator of erythropoiesis that is used for the treatment of chronic anaemia associated with RA (rheumatoid arthritis). Erythropoietin also appears to modulate a broad array of cellular processes, including progenitor stem-cell development, cellular integrity, angiogenesis and oxidative damage. These diverse activities suggest the exciting possibility of multiple roles for rHuEPO therapy in a variety of disorders other than RA, including cerebral ischaemia, myocardial infarction, chronic congestive heart failure and cancer. Thus it appears that rHuEPO may be a pleiotropic agent, capable of influencing tissue remodelling independently of its established erythropoietic role. Whereas these effects may be largely beneficial, dose-related side effects could have implications for the safe therapeutic use of rHuEPO and its illegal use as a performance-enhancing agent in endurance sports.
| Item Type: | Article |
|---|---|
| Research Area: | Pre-clinical and human biological sciences |
| Faculty, School or Research Centre: | Faculty of Science (until 2011) > School of Life Sciences |
| Related URLs: | |
| Depositing User: | Susan Miles |
| Date Deposited: | 04 Nov 2011 09:36 |
| Last Modified: | 04 Nov 2011 09:36 |
| URI: | http://eprints.kingston.ac.uk/id/eprint/21375 |
Actions (Repository Editors)
 |
Item Control Page |